To reconstitute a 5mg vial of Sermorelin for laboratory research, the volume of bacteriostatic water added depends on the desired target concentration for pipetting or automated assay systems. Reconstituting 5mg of Sermorelin with 1.0 mL yields a concentration of 5.0 mg/mL (5 µg/µL), 2.0 mL yields 2.5 mg/mL (2.5 µg/µL), and 2.5 mL yields 2.0 mg/mL (2.0 µg/µL).
To reconstitute a 5mg vial of Sermorelin for laboratory research, the volume of bacteriostatic water added depends on the desired target concentration for pipetting or automated assay systems. Reconstituting 5mg of Sermorelin with 1.0 mL yields a concentration of 5.0 mg/mL (5 µg/µL), 2.0 mL yields 2.5 mg/mL (2.5 µg/µL), and 2.5 mL yields 2.0 mg/mL (2.0 µg/µL).
Determining how much bacteriostatic water to mix with a 5mg vial of lyophilized Sermorelin depends entirely on the micro-volume measurements required for your experimental protocol. Sermorelin acetate is standardly supplied in 5mg (5000 micrograms) vacuum-sealed vials. When preparing stock solutions for in vitro receptor binding assays, cell-culture stimulation, or animal model administration, researchers must select a diluent volume that balances precise pipetting capabilities with solution stability.
The most common reconstitution volume used in research settings is 2.0 mL of bacteriostatic water. Adding 2.0 mL to 5mg of lyophilized powder produces a final concentration of 2.5 mg/mL (2500 µg/mL or 2.5 µg per microliter). This intermediate concentration allows high pipetting precision while maintaining complete dissolution of the peptide cake. Alternative volumetric calculations include:
• 1.0 mL diluent = 5.0 mg/mL final concentration (5.0 µg/µL) • 2.0 mL diluent = 2.5 mg/mL final concentration (2.5 µg/µL) • 2.5 mL diluent = 2.0 mg/mL final concentration (2.0 µg/µL) • 5.0 mL diluent = 1.0 mg/mL final concentration (1.0 µg/µL)
Selecting the proper diluent volume ensures that aliquots measured during experimental procedures fall within the optimal accuracy range of standard laboratory micropipettes, minimizing volumetric error during serial dilutions or micro-dosing protocols.
To calculate custom concentrations for specific assay designs, researchers utilize standard volumetric concentration formulas. The foundational equation governing peptide reconstitution is C = m / V, where C represents concentration, m represents total mass of the lyophilized peptide, and V represents total diluent volume.
To solve for final concentration in milligrams per milliliter (mg/mL):
C (mg/mL) = Mass of Sermorelin (mg) / Volume of Diluent (mL)
For example, if an automated micro-dispensing platform requires a working stock concentration of 2.0 mg/mL using a 5mg vial of sermorelin 5mg, the required diluent volume is calculated by rearranging the equation to V = m / C:
V = 5.0 mg / 2.0 mg/mL = 2.5 mL diluent
Converting to microgram-based metrics for cell-culture calculations follows the basic conversion: 1 mg = 1000 µg, and 1 mL = 1000 µL. Consequently, a 2.5 mg/mL solution translates directly to 2.5 µg/µL. Researchers seeking step-by-step mathematical models for complex diluent calculations can consult our comprehensive peptide reconstitution calculator guide.
Sermorelin is a synthetic peptide fragment representing the functional N-terminal sequence of native endogenous Growth Hormone-Releasing Hormone (GHRH). Comprising 29 amino acids, Sermorelin is structurally designated as GHRH(1-29) NH2. It contains the essential biological sequence required to bind and activate GHRH receptors on anterior pituitary somatotrophs.
The sequence of Sermorelin is Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2, with a molecular weight of approximately 3357.9 g/mol. The C-terminal amidation enhances structural stability relative to truncated non-amidated fragments.
In lyophilized form, high-purity Sermorelin appears as a dense white cake or crystalline powder. Due to its hydrophobic residue clusters, complete solubilization requires initial contact with a polar aqueous solvent containing an antimicrobial agent, such as 0.9% benzyl alcohol preserved water (bacteriostatic water). Complete breakdown of the peptide structure occurs if exposed to thermal extremes, high shear force, or unbuffered acidic/basic conditions.
In preclinical literature, Sermorelin is evaluated as a selective reference agonist for the GHRH receptor (GHRH-R), a Class B G-protein coupled receptor expressed predominantly in the adenohypophysis. In vitro receptor binding assays demonstrate that Sermorelin binds to GHRH-R with high affinity, stimulating the Gs alpha subunit pathway.
This activation triggers membrane-bound adenylyl cyclase, driving the intracellular accumulation of cyclic adenosine monophosphate (cAMP) and downstream activation of protein kinase A (PKA). PKA phosphorylation opens voltage-gated L-type calcium channels, inducing an influx of extracellular Ca2+ that stimulates the exocytosis of stored growth hormone (GH) vesicles.
Preclinical rodent models demonstrate that Sermorelin preserves the endogenous physiological feedback loops governing somatostatic control. Unlike direct growth hormone secretagogues or exogenous GH administration, GHRH(1-29) signaling remains susceptible to somatostatin (SRIF) inhibition. Consequently, researchers utilize Sermorelin to study regulated, pulsatile growth hormone secretion patterns and somatotroph responsiveness without permanently bypassing natural hypothalamic regulatory control mechanisms. Additional research on pituitary axis signaling can be explored in our GHRH analogs overview.
Within the category of synthetic GHRH receptor agonists, Sermorelin represents the shortest fully functional peptide sequence. However, modifications to the native GHRH chain have yielded alternative analogs designed for altered receptor binding kinetics and half-life extension in research models. Comparing these compounds highlights key differences in stability and structural modification.
When evaluating GHRH receptor agonists in laboratory models, Sermorelin is frequently compared alongside cjc-1295-no-dac and tesamorelin. Sermorelin consists of the truncated 29-amino acid sequence with an unmodified half-life (approximately 10–12 minutes in rodent plasma), making it ideal for acute signaling studies. In contrast, CJC-1295 (Mod GRF 1-29) incorporates four amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) designed to resist enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV). Tesamorelin incorporates a trans-3-hexenoic acid group attached to the N-terminus of the 44-amino acid GHRH sequence, enhancing enzymatic stability for targeted lipid metabolism research. Additionally, researchers studying synergistic GH release often pair GHRH agonists with growth hormone secretagogue receptor (GHSR) agonists such as ghrp-6 to observe dual-pathway activation in vitro.
To maintain sterility and structural integrity during reconstitution, laboratory personnel should follow standardized aseptic protocols inside a certified laminar flow hood or cleanroom station:
1. Remove the 5mg Sermorelin vial and bacteriostatic water from cold storage and allow them to equilibrate to ambient room temperature (20°C to 25°C) to prevent thermal shock to the lyophilized peptide matrix. 2. Sanitize the rubber septa of both the Sermorelin vial and diluent vial using 70% isopropyl alcohol wipes. Allow septa to air-dry completely. 3. Using a sterile, single-use laboratory syringe fitted with a high-gauge needle (e.g., 21G to 25G), draw the targeted volume of bacteriostatic water (e.g., 2.0 mL). 4. Insert the needle through the septum of the Sermorelin vial at a 45-degree angle. Direct the fluid stream against the inner glass wall of the vial rather than shooting liquid directly onto the lyophilized cake. 5. Allow the diluent to slowly submerge the powder. The internal vacuum should draw the liquid smoothly into the vial. 6. Gently swirl the vial in a smooth circular motion until the lyophilized matrix is fully dissolved. Never shake, vortex, or aggressively agitate reconstituted peptide solutions, as high mechanical shear stress causes irreversible tertiary protein denaturation and aggregation.
Lyophilized Sermorelin acetate exhibits long-term stability when stored under controlled freeze conditions. Unreconstituted vials supplied by PX1 Research should be stored in a commercial laboratory freezer at -20°C or below, protected from light exposure. Under these conditions, the lyophilized powder maintains structural purity for up to 24 months.
Once reconstituted with bacteriostatic water containing 0.9% benzyl alcohol, the aqueous Sermorelin solution must be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Benzyl alcohol acts as a bacteriostatic agent, inhibiting microbial proliferation in multi-dose lab vials. Reconstituted solutions stored at refrigerated temperatures remain stable for experimental use for 28 days.
Avoid repeated freeze-thaw cycles of reconstituted liquid, as ice crystal formation disrupts the peptide backbone and causes precipitation. For long-term analytical projects requiring single-use working samples, reconstitute using sterile water, aliquot immediately into sterile micro-centrifuge tubes, freeze at -80°C, and discard each aliquot immediately following experimental use. Additional handling procedures can be reviewed in the main research library.
Precision in laboratory research requires total confidence in chemical purity and batch consistency. Low-purity peptide reagents contain chemical synthesis byproducts, truncated amino acid sequences, and residual TFA (trifluoroacetic acid) salts that introduce unwanted variables into cell signaling assays and metabolic animal models.
Every lot of Sermorelin manufactured for PX1 Research undergoes stringent third-party testing in ISO 17025 accredited analytical laboratories. Quality verification requires two primary analytical methodologies:
• Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Measures chemical purity percentages by separating chemical species across a hydrophobic stationary phase. PX1 Research mandates a minimum baseline purity of ≥98.0% for all catalog compounds. • Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight and identity, confirming that the synthesized sequence matches the theoretical mass of 3357.9 Da without structural truncation or unwanted adducts.
Researchers can inspect and download lot-specific Certificates of Analysis (COAs) directly through our portal, ensuring full traceability from raw synthesis to final distribution.
In cell-culture applications and in vivo preclinical protocols, bacterial endotoxins (lipopolysaccharides derived from Gram-negative bacterial cell walls) introduce severe confounding variables. Endotoxin contamination triggers non-specific inflammatory signaling pathways, upregulating pro-inflammatory cytokines such as TNF-alpha and IL-6, which interfere with pituitary receptor binding data.
PX1 Research enforces strict endotoxin screening protocols using Chromogenic Limulus Amebocyte Lysate (LAL) testing assays. All research-grade Sermorelin lots are verified to contain endotoxin levels well below industry thresholds, capping bioburden at <0.01 EU/mg.
Additionally, our products are synthesized in state-of-the-art GMP-compliant facilities within the United States. Fast-dispatch logistics operate out of modern distribution centers in California and Arizona, providing same-day dispatch for orders finalized Monday through Friday prior to cutoff times. Institutional buyers requiring larger quantities for multi-phase laboratory studies can establish specialized accounts through our wholesale lab portal.
How much bacteriostatic water should be added to a 5mg Sermorelin vial?
The volume depends on the required experimental concentration. Adding 2.0 mL of bacteriostatic water creates a concentration of 2.5 mg/mL (2.5 µg/µL), while adding 1.0 mL creates a concentration of 5.0 mg/mL (5.0 µg/µL).
Can standard sterile water for injection be used instead of bacteriostatic water?
Sterile water lacks a bacteriostatic preservative (such as 0.9% benzyl alcohol). If sterile water is used, the reconstituted solution must be used immediately in a single experiment and discarded, as it lacks antimicrobial defense against multi-use septum punctures.
How should reconstituted 5mg Sermorelin be stored in the lab?
Reconstituted Sermorelin must be refrigerated at 2°C to 8°C (36°F to 46°F) and kept protected from direct light. Stored properly with bacteriostatic water, the solution remains stable for up to 28 days.
What is the primary target receptor for Sermorelin in preclinical models?
Sermorelin is a selective agonist for the GHRH receptor (GHRH-R), located on somatotroph cells in the anterior pituitary gland, where it stimulates cyclic AMP signaling and endogenous growth hormone release.
What purity level is guaranteed for PX1 Research Sermorelin?
PX1 Research guarantees a purity level of ≥98.0% for Sermorelin, verified by lot-specific Reverse-Phase HPLC and ESI-Mass Spectrometry analysis performed by independent ISO 17025 accredited laboratories.
How do you avoid damaging the peptide during reconstitution?
Direct the diluent stream against the glass wall of the vial rather than directly onto the lyophilized powder. Swirl the vial gently until fully dissolved; never vortex or shake reconstituted peptide solutions.
What is the endotoxin limit for PX1 Research peptides?
PX1 Research mandates strict endotoxin testing using chromogenic LAL assays, ensuring bioburden levels remain under <0.01 EU/mg to prevent inflammatory artifact interference in cell assays.
Where are PX1 Research compounds synthesized and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and dispatched directly from primary logistics hubs in California and Arizona with same-day shipping on weekday orders.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.